A tool developed in Singapore that takes less than 2 minutes to tell if a person has a major eye problem has just been approved for sale in Europe. The system, called Selena+, was developed jointly by SERI and the NUS School of Computing. It can tell from a photograph of the person's eye whether he has diabetic retinopathy, glaucoma or age-related macular degeneration with a greater than 90 percent accuracy. SingHealth holds the licence on behalf of Seri and NUS, and it has licensed it to local start-up EyRIS, which obtained the European Union approval, known as a CE mark.
Prof Wong Tien Yin, Medical Director, SNEC; DGCEO, SingHealth, was quoted in the story in his capacity as Seri Chairman and said that the CE mark will now allow a Singaporean company to provide this product in Europe. The article also noted that EyRIS signed an MOU with the Singapore Optometric Association last Thursday on the use of Selena+, and the partnership will provide even wider access to primary eye care for Singaporeans. Dr Gavin Tan, Head of Ocular Imaging, SNEC, was also quoted in the story.
Subcribe to our mailing list to get the latest education updates.